Insiders Penumbra, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2024-04-30 pm EDT			5-day change	1st Jan Change
196.5 ^USD	-2.76%		-4.49%	-21.89%

Apr. 23	Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots	CI
Apr. 17	DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment	MT

Penumbra Insider Sold Shares Worth $2,086,417, According to a Recent SEC Filing	23-10-16	MT
Penumbra Insider Sold Shares Worth $142,691, According to a Recent SEC Filing	23-10-05	MT
Penumbra Insider Sold Shares Worth $2,887,821, According to a Recent SEC Filing	23-09-14	MT
Insider Sell: Penumbra	23-08-15	MT
Insider Sell: Penumbra	23-07-14	MT
Insider Sell: Atricure	23-05-30	MT
Insider Sell: Penumbra	23-05-16	MT
Insider Sell: Penumbra	23-04-03	MT
Insider Sell: Penumbra	23-03-06	MT
Insider Sell: Penumbra	23-02-06	MT
Insider Sell: Penumbra	23-01-26	MT
Insider Sell: Penumbra	22-09-12	MT
Penumbra Chief Business Officer Lynn Rothman to Leave Next Month	22-04-08	MT
Lynn Rothman, the Executive Vice President and Chief Business Officer of Penumbra, Inc., Notifies Her Departure	22-04-08	CI
Insider Sell: Penumbra	22-01-14	MT
Insider Sell: Penumbra	22-01-06	MT
Insider Sell: Penumbra	22-01-06	MT
Insider Sell: Penumbra	21-12-16	MT
Insider Sell: Penumbra	21-10-06	MT
Insider Sell: Penumbra	21-10-06	MT

No results for this search

Penumbra, Inc. : The underdog in healthcare

April 11, 2024 at 09:39 pm EDT